Cas:4072-67-7 4,4′-Bis(2-bromoacetyl)biphenyl manufacturer & supplier

Chemical Name:4,4′-Bis(2-bromoacetyl)biphenyl

CAS.NO:4072-67-7

Synonyms:1,1′-(1,1′-Biphenyl)-4,4′-diylbis(2-bromoethan-1-one);einecs 223-785-3;1,1′-(4,4′-Biphenyldiyl)bis(2-bromoethanone);Ethanone, 1,1′-[1,1′-biphenyl]-4,4′-diylbis[2-bromo-;1,1′-biphenyl-4,4′-diylbis(2-bromoethanone);4,4′-Bis(2-bromoacetyl)biphenyl

Molecular Formula:C₁₆H₁₂Br₂O₂

Molecular Weight:396.073

HS Code:2914700090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:464.8±30.0 °C at 760 mmHg

Density:1.6±0.1 g/cm3

Index of Refraction:1.625

PSA:34.14000

Exact Mass:393.920380

LogP:4.10

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,1′-(1,1′-Biphenyl)-4,4′-diylbis(2-bromoethan-1-one) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,4′-Bis(2-bromoacetyl)biphenyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,4′-Bis(2-bromoacetyl)biphenyl Use and application,1,1′-(1,1′-Biphenyl)-4,4′-diylbis(2-bromoethan-1-one) technical grade,usp/ep/jp grade.

Related News: The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. 4,4′-Bis(2-bromoacetyl)biphenyl manufacturer Analysts at Jefferies, meanwhile, said the FDA accelerated approval for Aduhelm, which was based on a surrogate endpoint of amyloid beta plaque reduction (and not clinical benefit) “has implications for ongoing AD studies,” most notably, it reckons, for Roche’s phase 3 GRADUATE test for its anti-amyloid-beta candidate gantenerumab, “as a much lower hurdle than demonstrating clear cognitive benefit” has now become precedent. Jefferies, still cautious, said it remains “unclear what stance FDA may take for the field if GRADUATE fails on cognition despite significant Abeta reductions,” but says it’s probably not going to revive Roche-AC Immune’s anti-amyloid-beta candidate crenezumab, which saw its late-stage CREAD trials discontinued for futility but which is currently in an Alzheimer’s prevention study. 4,4′-Bis(2-bromoacetyl)biphenyl supplier United Airlines — which announced that it will suspend flights to Beijing, Chengdu and Shanghai from February 6 — is also reducing flights from the US to Hong Kong. 4,4′-Bis(2-bromoacetyl)biphenyl vendor United Airlines — which announced that it will suspend flights to Beijing, Chengdu and Shanghai from February 6 — is also reducing flights from the US to Hong Kong. 4,4′-Bis(2-bromoacetyl)biphenyl factory The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful.